

%201.webp)



%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。



%201.webp)



%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

In Malaysia, the National Pharmaceutical Regulatory Agency (NPRA) is spearheading a transformative approach to pharmaceutical supply chain security through its comprehensive Track & Trace pilot project. This regulatory initiative represents Malaysia's commitment to combating counterfeit medicines, enhancing supply chain transparency, and ultimately safeguarding patient safety across the nation's healthcare ecosystem.
%201.webp)
NPRA mandates that all pharmaceutical products must display essential information in writing directly on their packaging. This requirement ensures that critical product details remain visible and accessible throughout every stage of the supply chain, enabling healthcare professionals and regulatory authorities to verify product authenticity and maintain proper handling protocols.
Each sellable unit of pharmaceutical products must carry a unique identifier through serialization technology. This distinctive coding system assigns individual serial numbers to every product unit, creating a digital fingerprint that enables precise tracking, verification, and authentication throughout the entire distribution network from manufacturer to end consumer.
The system requires comprehensive identification and documentation of packaging relationships across all levels. This encompasses the clear mapping of connections between primary packaging (such as blister packs), secondary packaging (boxes), and tertiary packaging (shipping cartons), ensuring complete traceability from the smallest sellable unit to larger distribution containers.
NPRA's pilot project establishes a structured compliance framework that aligns with international pharmaceutical supply chain security standards. The initiative includes systematic oversight mechanisms, regular monitoring protocols, and standardized reporting procedures to ensure pharmaceutical stakeholders maintain adherence to track and trace requirements while supporting broader public health objectives.
Our team of compliance experts possesses in-depth knowledge of iTS and Turkish pharmaceutical regulations. From serialization strategies to data reporting, we guide your organization through the intricacies of compliance, ensuring a smooth and informed journey.
Leverage our state-of-the-art compliance solution, designed to integrate seamlessly with iTS requirements. Our technology ensures accuracy, efficiency, and real-time visibility, empowering your organization to meet and exceed compliance expectations.
Compliance is not just about meeting today's standards; it's about preparing for the future. Our solution is designed to evolve with regulatory changes, ensuring that your organization remains at the forefront of compliance in the dynamic Turkish pharmaceutical landscape.
We believe in transparent collaboration. Partner with us, and we'll work closely with your team to implement and maintain compliance measures. Our goal is to build a resilient, compliant, and future-ready pharmaceutical supply chain together.


Successfully implementing Malaysia's NPRA Track & Trace requirements demands specialized knowledge and strategic planning. LSPedia's experienced team provides comprehensive solutions for pharmaceutical organizations navigating this regulatory landscape. Our expertise encompasses serialization implementation, packaging hierarchy mapping, data integration systems, and compliance monitoring tools. We guide pharmaceutical entities through every aspect of the track and trace process, ensuring seamless integration with existing operations while maintaining full regulatory compliance and fostering a transparent, secure pharmaceutical supply chain that meets NPRA's evolving standards.




We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.
Stay connected with us on social media and subscribe to our newsletter to receive the latest updates, insights, and innovations from LSPedia.
Pharmaceutical products in Malaysia are regulated by the National Pharmaceutical Regulatory Agency (NPRA) under the Ministry of Health Malaysia. Malaysia has implemented a national pharmaceutical verification and traceability initiative to improve supply chain transparency and prevent counterfeit medicines.
Malaysia operates the Pharmaceutical Track and Trace System (Pharma T&T), which requires pharmaceutical products to carry GS1 compliant DataMatrix barcodes with serialized identifiers. The system enables tracking and verification of medicines throughout the pharmaceutical supply chain.
The Pharma T&T framework supports digital reporting of medicine movement from manufacturers and importers through distributors to pharmacies. The system aims to improve regulatory oversight, protect patients from falsified medicines, and strengthen the integrity of the pharmaceutical supply chain.
Implementation has been phased, with serialization requirements initially applied to selected pharmaceutical products and progressively expanded.
Pharmaceutical products distributed in Malaysia must include a 2D DataMatrix barcode applied to the secondary packaging.
The DataMatrix must comply with GS1 standards and typically contains the following data elements:
These identifiers allow each medicine pack to be uniquely identified and verified through the national traceability system.
Human readable information printed on the packaging must correspond to the encoded barcode data.
2017–2018
Malaysia began developing a national pharmaceutical traceability strategy to strengthen medicine supply chain monitoring.
2019 onward
The Pharmaceutical Track and Trace System (Pharma T&T) was introduced to support serialization and digital verification of medicines.
Current Status
Serialization and traceability requirements are being implemented in phases across the pharmaceutical supply chain.
Supply chain participants must ensure accurate reporting of serialization data to maintain traceability.
| Operation | Data to Report | When to Report |
Commission | GTIN, Serial, Batch, Expiry Parent SSCC, Child Serials Sender GLN, Receiver GLN, SSCC or Serial List | During packaging before shipment When creating cases or pallets Before dispatch |
ReceivingImport Clearance Supply to Pharmacy | GTIN, Serial, Batch, Expiry Parent SSCC, Child Serials Sender GLN, Receiver GLN, SSCC or Serial List | During packaging before shipment When creating cases or pallets Before dispatch |
Returns Decommission | Serial status and reference Reason and serials | When return is approved When product is destroyed or removed |
Traceability reporting in Malaysia is managed through the Pharmaceutical Track and Trace System (Pharma T&T) operated by the Ministry of Health through the National Pharmaceutical Regulatory Agency.
The system enables supply chain participants to report serialization data and product movement through electronic interfaces and APIs.
Participants interacting with the system include:
The platform supports:
Malaysia’s pharmaceutical traceability system focuses primarily on unit level serialization using DataMatrix barcodes.
Aggregation at case or pallet level is not explicitly mandated in publicly available regulatory guidance. Pharmaceutical companies may implement aggregation internally to support warehouse automation and logistics operations.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.